{"id":1109,"date":"2020-03-17T13:14:43","date_gmt":"2020-03-17T13:14:43","guid":{"rendered":"https:\/\/www.almacgroup.com\/diagnostics\/?post_type=diagnostic_resource&#038;p=1109"},"modified":"2025-02-26T08:38:13","modified_gmt":"2025-02-26T08:38:13","slug":"optimizing-assays-from-ffpe-for-biomarker-strategies","status":"publish","type":"diagnostic_resource","link":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/","title":{"rendered":"Optimizing Assays from FFPE for Biomarker Strategies"},"content":{"rendered":"\n<p>The field of personalised medicine is developing rapidly and companion diagnostic approvals are becoming more and more common. To date, however, the vast majority of tests are relatively low complexity DNA or protein based assays. In our experience, more complex gene signature based tests are beginning to enter the pipeline with many of our clients currently using these tests for trial enrichment strategies as early as Phase I.<\/p>\n\n\n\n<p>When it comes to clinical delivery of such assays, the ability to work with FFPE tissue is critically important. This is an area of significant experience and expertise for Almac and in this webinar we will present some of our experience.<\/p>\n\n\n\n<p>Some of the key components will be:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Platforms, platform selection and migration<\/li><li>Optimizing tests for FFPE tissue<\/li><li>Clinical delivery for trial enrichment<\/li><li>Development routes for companion diagnostics<\/li><\/ul>\n\n\n\n<p>Speaker for this Event:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Dr. Austin Tanney, Scientific Liaison Manager, Almac<\/li><\/ul>\n\n\n\n<p><strong>Please complete the&nbsp;form below to view webinar:<\/strong><\/p>\n\n\n\n","protected":false},"featured_media":0,"template":"","diagnostics_type":[474],"class_list":["post-1109","diagnostic_resource","type-diagnostic_resource","status-publish","hentry","diagnostics_type-diagnostics-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3.1 (Yoast SEO v26.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Optimizing Assays from FFPE for Biomarker Strategies - Diagnostic Services<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Optimizing Assays from FFPE for Biomarker Strategies\" \/>\n<meta property=\"og:description\" content=\"The field of personalised medicine is developing rapidly and companion diagnostic approvals are becoming more and more common. To date, however, the vast majority of tests are relatively low complexity DNA or protein based assays. In our experience, more complex gene signature based tests are beginning to enter the pipeline with many of our clients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/\" \/>\n<meta property=\"og:site_name\" content=\"Diagnostic Services\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-26T08:38:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/11\/Almac_Logo-e1698941154737.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"100\" \/>\n\t<meta property=\"og:image:height\" content=\"52\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/\",\"name\":\"Optimizing Assays from FFPE for Biomarker Strategies - Diagnostic Services\",\"isPartOf\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\"},\"datePublished\":\"2020-03-17T13:14:43+00:00\",\"dateModified\":\"2025-02-26T08:38:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.almacgroup.com\/diagnostics\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Optimizing Assays from FFPE for Biomarker Strategies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"name\":\"Diagnostic Services\",\"description\":\"Just another Almac Core Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\",\"name\":\"Almac Group Ltd\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"width\":643,\"height\":296,\"caption\":\"Almac Group Ltd\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Optimizing Assays from FFPE for Biomarker Strategies - Diagnostic Services","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/","og_locale":"en_GB","og_type":"article","og_title":"Optimizing Assays from FFPE for Biomarker Strategies","og_description":"The field of personalised medicine is developing rapidly and companion diagnostic approvals are becoming more and more common. To date, however, the vast majority of tests are relatively low complexity DNA or protein based assays. In our experience, more complex gene signature based tests are beginning to enter the pipeline with many of our clients [&hellip;]","og_url":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/","og_site_name":"Diagnostic Services","article_modified_time":"2025-02-26T08:38:13+00:00","og_image":[{"width":100,"height":52,"url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/11\/Almac_Logo-e1698941154737.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/","url":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/","name":"Optimizing Assays from FFPE for Biomarker Strategies - Diagnostic Services","isPartOf":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website"},"datePublished":"2020-03-17T13:14:43+00:00","dateModified":"2025-02-26T08:38:13+00:00","breadcrumb":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.almacgroup.com\/diagnostics\/diagnostic-resource\/optimizing-assays-from-ffpe-for-biomarker-strategies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.almacgroup.com\/diagnostics\/"},{"@type":"ListItem","position":2,"name":"Optimizing Assays from FFPE for Biomarker Strategies"}]},{"@type":"WebSite","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website","url":"https:\/\/www.almacgroup.com\/diagnostics\/","name":"Diagnostic Services","description":"Just another Almac Core Sites site","publisher":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization","name":"Almac Group Ltd","url":"https:\/\/www.almacgroup.com\/diagnostics\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/","url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","contentUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","width":643,"height":296,"caption":"Almac Group Ltd"},"image":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.almacgroup.com\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource\/1109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.almacgroup.com\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource"}],"about":[{"href":"https:\/\/www.almacgroup.com\/diagnostics\/wp-json\/wp\/v2\/types\/diagnostic_resource"}],"wp:attachment":[{"href":"https:\/\/www.almacgroup.com\/diagnostics\/wp-json\/wp\/v2\/media?parent=1109"}],"wp:term":[{"taxonomy":"diagnostics_type","embeddable":true,"href":"https:\/\/www.almacgroup.com\/diagnostics\/wp-json\/wp\/v2\/diagnostics_type?post=1109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}